Tectonic Therapeutic, Inc. (TECX)
TECX Stock Price Chart
Explore Tectonic Therapeutic, Inc. interactive price chart. Choose custom timeframes to analyze TECX price movements and trends.
TECX Company Profile
Discover essential business fundamentals and corporate details for Tectonic Therapeutic, Inc. (TECX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
21 Jun 2018
Employees
51.00
Website
https://tectonictx.comCEO
Alise S. Reicin
Description
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
TECX Financial Timeline
Browse a chronological timeline of Tectonic Therapeutic, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$1.35.
Earnings released on 7 May 2026
EPS came in at -$1.34 falling short of the estimated -$1.16 by -15.52%.
Earnings released on 26 Feb 2026
EPS came in at -$1.03 surpassing the estimated -$1.11 by +7.21%.
Earnings released on 6 Nov 2025
EPS came in at -$1.02 surpassing the estimated -$1.05 by +2.86%.
Earnings released on 7 Aug 2025
EPS came in at -$1.07 falling short of the estimated -$0.98 by -9.18%.
Earnings released on 8 May 2025
EPS came in at -$0.93 surpassing the estimated -$1.10 by +15.45%.
Earnings released on 20 Mar 2025
EPS came in at -$0.84 surpassing the estimated -$1.39 by +39.57%.
Earnings released on 7 Nov 2024
EPS came in at -$1.20 falling short of the estimated -$0.84 by -42.86%.
Earnings released on 14 Aug 2024
EPS came in at -$3.81 falling short of the estimated -$1.96 by -94.39%.
Stock split effective on 21 Jun 2024
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 May 2024
EPS came in at -$1.80 surpassing the estimated -$4.32 by +58.33%.
Earnings released on 14 Mar 2024
EPS came in at -$2.40 surpassing the estimated -$4.04 by +40.59%.
Earnings released on 29 Sept 2023
EPS came in at -$5.81 falling short of the estimated -$4.22 by -37.67%.
Earnings released on 29 Jun 2023
EPS came in at $18.29 surpassing the estimated -$6.49 by +381.78%.
Earnings released on 30 Mar 2023
EPS came in at -$6.80 falling short of the estimated -$6.45 by -5.51%.
Earnings released on 31 Dec 2022
EPS came in at -$6.86 falling short of the estimated -$5.91 by -16.00%.
Earnings released on 29 Sept 2022
EPS came in at -$6.30 surpassing the estimated -$6.60 by +4.59%.
Earnings released on 29 Jun 2022
EPS came in at -$7.70 .
Earnings released on 30 Mar 2022
EPS came in at -$8.19 falling short of the estimated -$6.87 by -19.32%.
Earnings released on 30 Dec 2021
EPS came in at -$7.76 .
Earnings released on 29 Sept 2021
EPS came in at -$8.97 .
TECX Stock Performance
Access detailed TECX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
